Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
Transplantation|May 23, 2009
Kidneys from deceased donors more than 75 years perform acceptably after transplantationAksel Foss, Kristian Heldal, Helge Scott, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 30, 2009
Benefit of kidney transplantation beyond 70 years of ageKristian Heldal, Anders Hartmann, Diana C Grootendorst, et al.
BMC Nephrology|January 13, 2017
Should patients older than 65 years be offered a second kidney transplant?Kristian Heldal, Anders Hartmann, Kjersti Lønning, et al.
Clinical Kidney Journal|December 7, 2019
Kidney transplantation: an attractive and cost-effective alternative for older patients? A cost-utility studyKristian Heldal, Karsten Midtvedt, Kjersti Lønning, et al.
Transplantation Direct|October 17, 2022
Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort StudyVasiliki Tsarpali, Karsten Midtvedt, Kjersti Lønning, et al.
Kidney Medicine|December 23, 2021
Health-Related Quality of Life in Older Kidney Transplant Recipients: A National Cohort Study of Short- and Longer-Term OutcomesVasiliki Tsarpali, Karsten Midtvedt, Kjersti Lønning, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort studyKristian Heldal, Karsten Midtvedt, Anders Hartmann, et al.
Eclinicalmedicine|June 26, 2023
Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort studyMarkus Hovd, Anders Åsberg, Ludvig A Munthe, et al.
Transplantation Direct|March 30, 2022
A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective StudyVasiliki Tsarpali, Karsten Midtvedt, Kjersti Lønning, et al.
BMJ Open|June 18, 2026
Can sodium-glucose cotransporter 2 (SGLT2) inhibition preserve renal structure and function in de novo kidney transplant recipients? Protocol for a randomised, double-blind, placebo-controlled trial assessing the efficacy of dapagliflozin on kidney structure, function and safety in kidney transplant recipients in Norway-the DEAK studyIngrid Charlotte Kongerud, Karsten Midtvedt, Marit D Solbu, et al.
Pageof 17